FIELD: medicine.
SUBSTANCE: functional class of chronic cardiac failure, presence or absence of ST segment depression are stated. Measuring a thickness and mobility of vascular walls, R and S wave amplitude, left ventricular volume is followed by calculating a function by original formula. If the function is less than -51, the patient is referred to a group of secondary myocardial hypertrophy; the function of more than -0.51 shows hypertrophic non-obstructive cardiomyopathy.
EFFECT: technique enables conducting the differential diagnosis of hypertrophic non-obstructive cardiomyopathy and 'secondary' myocardial hypertrophy and prescribing an timely adequate therapy.
5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTHROPHIC CARDIOMYOPATHIA AND HYPERTENSION DISEASE WITH LEFT VENTRICULAR HYPERTROPHY | 2007 |
|
RU2370214C2 |
METHOD FOR PREDICTING SYNDROME OF INCOMPLETE DIASTOLE IN PATIENTS WITH IDIOPATHIC HYPERTROPHIC CARDIOMYOPATHY | 2004 |
|
RU2265399C2 |
SCREENING DIAGNOSTIC TECHNIQUE FOR HEART DISEASES | 2014 |
|
RU2551347C1 |
METHOD FOR SURGICAL TREATMENT OF HYPERTROPHIC NON OBSTRUCTIVE CARDIOMYOPATHY | 2003 |
|
RU2253373C2 |
METHOD OF EFFECTIVE DOSE SELECTION OF BETA-ADRENERGIC BLOCKING AGENTS IN CARDIOMYOPATHIES IN CHILDREN | 2019 |
|
RU2719909C1 |
METHOD TO PREDICT DIASTOLIC FAILURE OF LEFT VENTRICLE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY | 1993 |
|
RU2088146C1 |
METHOD FOR PRELIMINARY DIAGNOSTICS OF ISCHEMIC HEART DISEASE IN PATIENTS AFFECTED WITH HYPERTENSIVE DISEASE IN PRESENCE OF LEFT VENTRICLE MYOCARDIUM HYPERTROPHY | 1992 |
|
RU2078538C1 |
METHOD FOR DETECTING LEFT AURICULAR REMODELLING ACCOMPANYING HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE DISEASE BY CALCULATING LEFT AURICULAR REMODELLING COEFFICIENT IN TWO-DIMENSIONAL ECHOCARDIOGRAPHY | 2014 |
|
RU2574712C1 |
METHOD FOR EVALUATING CLINICAL EFFICIENCY OF USING VERAPAMYL AND DILTHIAZEM IN PATIENTS AFFECTED WITH HYPERTROPHIC CARDIOMYOPATHY | 1993 |
|
RU2078536C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
Authors
Dates
2015-11-10—Published
2014-10-21—Filed